Genelux Corp. (GNLX) at a glance

Genelux Corp. (GNLX) is a micro-cap Healthcare company. It trades at $2.77, with a 0% profit margin and revenue decline of 100%. It does not pay a dividend. Vestovix scores it 35/100 overall. Its strongest dimension is Value (50/100) and its weakest is Growth (12/100).

Price
$2.77
Market cap
$132.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$2.29 to $8.54
Vestovix Score35/ 100How this works
Value
50
Growth
12
Income
40
Safety
46
Momentum
18

Other Healthcare stocks

See all